New hope for advanced lung cancer patients in clinical trial
NCT ID NCT06512051
Summary
This study is testing a new combination of cancer drugs for people with advanced or spreading non-small cell lung cancer. Researchers want to find the safest and most effective dose and see how well the treatment shrinks tumors. The trial will involve about 248 adults and combines an experimental drug with an existing immunotherapy, with or without other cancer therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese People's Liberation Army General Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.